載入...
Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone
The C-C chemokine ligand 2 (CCL2) stimulates migration, proliferation, and invasion of prostate cancer (PCa) cells, and its signaling also plays a role in the activation of osteoclasts. Therefore targeting CCL2 signaling in regulation of tumor progression in bone metastases is an area of intense res...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Molecular Diversity Preservation International (MDPI)
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3676850/ https://ncbi.nlm.nih.gov/pubmed/23698775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms140510483 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|